88 research outputs found

    Accumulation of 15-Kilodalton Zein in Novel Protein Bodies in Transgenic Tobacco

    Full text link

    Quantum impurity dynamics in two-dimensional antiferromagnets and superconductors

    Full text link
    We present the universal theory of arbitrary, localized impurities in a confining paramagnetic state of two-dimensional antiferromagnets with global SU(2) spin symmetry. The energy gap of the host antiferromagnet to spin-1 excitations, \Delta, is assumed to be significantly smaller than a typical nearest neighbor exchange. In the absence of impurities, it was argued in earlier work (Chubukov et al. cond-mat/9304046) that the low-temperature quantum dynamics is universally and completely determined by the values of \Delta and a spin-wave velocity c. Here we establish the remarkable fact that no additional parameters are necessary for an antiferromagnet with a dilute concentration of impurities, n_{imp} - each impurity is completely characterized by a integer/half-odd-integer valued spin, S, which measures the net uncompensated Berry phase due to spin precession in its vicinity. We compute the impurity-induced damping of the spin-1 collective mode of the antiferromagnet: the damping occurs on an energy scale \Gamma= n_{imp} (\hbar c)^2/\Delta, and we predict a universal, asymmetric lineshape for the collective mode peak. We argue that, under suitable conditions, our results apply unchanged (or in some cases, with minor modifications) to d-wave superconductors, and compare them to recent neutron scattering experiments on YBCO by Fong et al. (cond-mat/9812047). We also describe the universal evolution of numerous measurable correlations as the host antiferromagnet undergoes a quantum phase transition to a Neel ordered state.Comment: 36 pages, 12 figures; added reference

    Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

    Get PDF
    Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection
    corecore